Excellent post Psilo and Astro and others. I find this discussion fascinating and so very necessary---if only we could broaden it to include the neuro degenerate disease-diagnosed crowd. It's growing. They are generally not enlightened but that is the fault and design of the medical/pharmeucitical industry.
Yes Astro - that is Tom Grier. He's done excellent research.
Here is part 2 of that article by Dana Parish (Lyme patient) of her interview w/ Dr Phillips (well-known LLMD in CT) that has a piece on that development of MS from a bacterial infection:
Part 1:
www.huffingtonpost.com/dana-parish/where-cdc-guidelines-fail-leading-lyme-doctor-succeeds-part-1_b_9318660.htmlPart 2:
www.huffingtonpost.com/dana-parish/where-idsa-guidelines-fail-leading-lyme-doctor-succeeds-part-ii_b_9352982.html And more info on the infectious origins of these "diseases" -
ABX working for MS:
www.nejm.org/doi/10.1056/NEJMoa1608889
/www.lymedisease.org/lymepolicywonk-antibiotics-treating-ms/
minocycline slowed MS development
www.healingwell.com/community/default.aspxf=30&m=3859953ALS
lymemd.blogspot.com/search?updated-min=2016-01-01T00:00:00-08:00&updated-max=2017-01-01T00:00:00-08:00&max-results=9www.blog.parkinsonsrecovery.com/category/lyme-disease/*********
ALS dx:
ALS, MS, ME, fibromyalgia, chronic fatigue syndrome, and several other "conditions" are really names given to groups of symptoms that the medical community has not determined causes for… that really isn't a diagnosis, it'a a guess based on symptoms and common understandings among the medical community. It's an admission of, "we don't really know for sure, but it looks like X."
Also, with diagnoses of symptoms, big pharma has reason to fund research to develop profitable corresponding pharmaceuticals designed to mask symptoms, not eradicate root causes of the illness.
Anyone who has done their homework, as most of us here have, knows that in order to get to the root causes of symptoms, you have to dig deeper. Lyme has a known cause and varied viable treatments and people have recovered. Many similar sx of ALS have been found as common lyme sx.
Additionally, Researcher Alan MacDonald, MD has been studying lyme disease for 30 yrs and came across an amazing discovery while analyzing brain specimens of Alzheimer's victims: 70% of these Alzheimer’s-riddled brains contained the Lyme bacteria Borrelia.
Dr. Dietrich Klinghardt, another Lyme specialist, states he’s "never had a single patient with Alzheimer’s, ALS, Parkinson’s disease or multiple sclerosis who did not test positive for Borrelia." These are all diseases with no known cause and he suspects that Lyme disease might be the common link.
These sufferers have been given a death sentence and are leaving no stone unturned trying to help themselves, when the medical industry has failed them. Exactly what I would do.
ALZ
glutathione:
lymemd.blogspot.com/2013/10/lyme-disease-alzheimers-disease.htmlALSO -
Mycoplasma and other Intracellular Bacterial Infections in Rheumatic Diseases: Comorbid Condition or Cause?
open Journal of Tropical Medicine
(Letter to the editor)
Garth L Nicolson
Department of Molecular Pathology, The Institute for Molecular Medicine, Huntington Beach, California 92647, USA
The U.S. National Institutes of Health sponsored a double-blind, placebo controlled, long-term clinical trial that showed that the antibiotic minocycline was safe and effective for the treatment of rheumatoid arthritis. The antibiotic-treated patients showed greater improvements in joint swelling and tenderness (p<0.02), and the treatment group also had better improvements in hematocrit, SED rate, platelet counts and rheumatoid factor with no serious toxicity [27, 28]. A 4-year follow-up indicated that the minocycline-treated patients had fewer relapses and less frequent need for immune-suppressive drugs to control their RA (p<0.02) [29]. Although treatment of arthritis with antibiotics was effective and safe, treatment failures can, just as in any treatment for arthritis, be due to therapeutic failures, resistance and/or mutation of the microorganism [30].
Part of the reason that most rheumatic disease patients do not receive antibiotic treatment may have more to do with the enormous pressure from the marketing and sales of various drugs that do little to address the underlying causes of rheumatic diseases than the effectiveness of various treatments.
In summary, intracellular bacteria are commonly linked to rheumatic diseases, especially rheumatoid arthritis and similar conditions, and these infections can be successfully treated with antibiotics. Treatment often but not always resulted in significant reductions in rheumatic signs and symptoms.Thus chronic infections, such as intracellular bacterial infections, do not appear to be simply co-morbid conditions in rheumatic
disease patients. "
/www.researchgate.net/publication/318311548_Mycoplasma_and_other_Intracellular_Bacterial_Infections_in_Rheumatic_Diseases_Comorbid_Condition_or_Cause-p
Post Edited (Pirouette) : 9/24/2017 10:21:04 AM (GMT-6)